8-K 5.02 NEW DIRECTOR

Company

CUMBERLAND PHARMACEUTICALS INC

Filed

September 21, 2018

Period of Report

September 21, 2018

Accession Number

0001628280-18-012030

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →